Diabetes mellitus tipo 2 en la infancia

Banerji M. Diabetes in African Americans: unique pathophysiologic features. Curr Diab Rep 2004; 4: 219-23.

Copeland KC, Zeitler P, Geffner M, et al. TODAY Study Group. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J Clin Endocrinol Metab 2011; 96: 159-67.

Dart AB, Martens PJ, Rigatto C, Brownell MD, Dean HJ, Sellers EA. Earlier onset of complications in youth with type 2 diabetes. Diabetes Care 2014; 37: 436-43.

Dixon J, O’Brien P, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes. JAMA 2008; 299: 316-23.

Ehtisham S, Barrett T, Shaw N. Type 2 diabetes mellitus in children - an emerging problem. Diabet Med 2000; 17: 867-71.

Haines L, Wan K, Lynn R, Barrett T, Shield J. Rising incidence of type 2 diabetes in children in the United Kingdom. Diabetes Care 2007; 30: 1097-101.

Kelsey MM, Geffner ME, Guandalini C, et al. Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) Study Group. Presentation and effectiveness of early treatment of type 2 diabetes in youth: lessons from the TODAY study. Pediatr Diabetes 2016; 17: 212-21.

Klingensmith G, Pyle L, Arslanian S, et al. for the TODAY Study Group. The presence of GAD and IA2 antibodies in youth with a type 2 diabetes phenotype. Diabetes Care 2010; 33: 1970-5.

Lee-Jones K, Arslanian S, Peterokova V, Park J, Tomlinson M. Effect of metformin in paediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 2002; 25: 89-94.